Clinical Research Directory
Browse clinical research sites, groups, and studies.
Luminal Fructose Kinetics (MARTINI Study)
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Summary
In this study the investigators aim is to explore the dynamics of (small) intestinal fructose catabolism in humans and ethanol production in relation to small intestinal signalling pathways and changes in pH, using 13C fructose isotope tracing techniques complemented with direct luminal sampling via small intestinal catheter in biopsy proven MASLD/MASH patients vs healthy (BMI\<25) subjects. Additionally the investigators will repeat the experiment after four weeks of administering omeprazole at a dose of 40 mg twice daily. Omeprazole is a proton pump inhibitor, known to elevate pH from 2-6.
Official title: Luminal Fructose Kinetics (MARTINI) (2024)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
22
Start Date
2024-07-01
Completion Date
2026-04
Last Updated
2024-08-06
Healthy Volunteers
Yes
Conditions
Interventions
Omeprazole 40 MG
Proton pump inhibitor twice a day for 4 weeks
Locations (1)
Amsterdam UMC location AMC
Amsterdam, Netherlands